{"title":"的木酚素","authors":"Anna K. F. Albertson, J. Lumb","doi":"10.1002/9781119427896.CH1","DOIUrl":null,"url":null,"abstract":"Nature has long served as an important source of therapeutics, and lignans represent a large class of pharmacologically active compounds (Cunha et al. 2012). This family of molecules demonstrates a wide range of biological activities, which plants use as a front‐line chemical defence against pathogens (Figure 1.1). Additionally, the anticancer, antimiotic, antiangiogenesis and antiviral properties possessed by lignans have made them appealing drug candidates, as well as starting points for drug discovery. Lignans currently employed for healthcare include (−)‐podophyllotoxin (1), a treatment for warts, and its derivatives (−)‐etoposide (2) and (−)‐teniposide (3), two potent chemotherapeutic agents (Liu et al. 2007). Other members of this class with promising biological activities include (+)‐gomisin J (4) and (+)‐pinoresinol (5). Due to the established benefits of the lignans, both their biosynthesis and synthetic strategies to access them have been areas of extensive research. In addition to their varied biological activities, lignans comprise a vast array of structurally distinct skeletons (Figure 1.2), including 6‐ and 8‐membered carbocycles (6, 7), linear dibenzylbutanes (8), and diversely oxidized tetrahydrofurans (9–11). Remarkably, their biosynthesis originates from a regio‐ and stereoselective, oxidative coupling of relatively simple monolignols (propenyl phenols) (12), to form the key 8–8 bond that serves to characterize all lignan natural products. Subsequent transformations, including cyclization and oxidation of the parent scaffold, convert the initially formed dimer to various family members, imparting unique functionalities. While this blueprint has served as a key source of inspiration for decades of biomimetic synthetic approaches to the lignans, issues of selectivity in the oxidative coupling have led researchers to alternative, target‐oriented routes, which are often specific for an individual structural class. In this review, we summarize these recent efforts from 2009 to 2016, and provide an overview of contemporary research efforts interrogating the lignans. Previous The Lignans","PeriodicalId":246207,"journal":{"name":"Recent Advances in Polyphenol Research","volume":"85 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"The Lignans\",\"authors\":\"Anna K. F. Albertson, J. Lumb\",\"doi\":\"10.1002/9781119427896.CH1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Nature has long served as an important source of therapeutics, and lignans represent a large class of pharmacologically active compounds (Cunha et al. 2012). This family of molecules demonstrates a wide range of biological activities, which plants use as a front‐line chemical defence against pathogens (Figure 1.1). Additionally, the anticancer, antimiotic, antiangiogenesis and antiviral properties possessed by lignans have made them appealing drug candidates, as well as starting points for drug discovery. Lignans currently employed for healthcare include (−)‐podophyllotoxin (1), a treatment for warts, and its derivatives (−)‐etoposide (2) and (−)‐teniposide (3), two potent chemotherapeutic agents (Liu et al. 2007). Other members of this class with promising biological activities include (+)‐gomisin J (4) and (+)‐pinoresinol (5). Due to the established benefits of the lignans, both their biosynthesis and synthetic strategies to access them have been areas of extensive research. In addition to their varied biological activities, lignans comprise a vast array of structurally distinct skeletons (Figure 1.2), including 6‐ and 8‐membered carbocycles (6, 7), linear dibenzylbutanes (8), and diversely oxidized tetrahydrofurans (9–11). Remarkably, their biosynthesis originates from a regio‐ and stereoselective, oxidative coupling of relatively simple monolignols (propenyl phenols) (12), to form the key 8–8 bond that serves to characterize all lignan natural products. Subsequent transformations, including cyclization and oxidation of the parent scaffold, convert the initially formed dimer to various family members, imparting unique functionalities. While this blueprint has served as a key source of inspiration for decades of biomimetic synthetic approaches to the lignans, issues of selectivity in the oxidative coupling have led researchers to alternative, target‐oriented routes, which are often specific for an individual structural class. In this review, we summarize these recent efforts from 2009 to 2016, and provide an overview of contemporary research efforts interrogating the lignans. Previous The Lignans\",\"PeriodicalId\":246207,\"journal\":{\"name\":\"Recent Advances in Polyphenol Research\",\"volume\":\"85 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Recent Advances in Polyphenol Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/9781119427896.CH1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent Advances in Polyphenol Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/9781119427896.CH1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
长期以来,大自然一直是治疗药物的重要来源,木脂素代表了一大类具有药理活性的化合物(Cunha et al. 2012)。这一分子家族表现出广泛的生物活性,植物将其作为对抗病原体的一线化学防御(图1.1)。此外,木脂素所具有的抗癌、抗微生物、抗血管生成和抗病毒特性使它们成为有吸引力的候选药物,也是药物发现的起点。目前用于医疗保健的木脂素包括(−)‐足臼毒素(1),一种治疗疣的药物,及其衍生物(−)‐足臼苷(2)和(−)‐天尼泊苷(3),两种有效的化疗药物(Liu et al. 2007)。该类别中具有生物活性的其他成员包括(+)‐gomisin J(4)和(+)‐pinresinol(5)。由于木脂素的已知益处,它们的生物合成和获取它们的合成策略都是广泛研究的领域。除了具有不同的生物活性外,木脂素还包含大量结构独特的骨架(图1.2),包括6元和8元碳环(6,7),线性二苄基丁烷(8)和不同氧化的四氢呋喃(9-11)。值得注意的是,它们的生物合成源于相对简单的单脂醇(丙烯酚)的区域和立体选择性氧化偶联(12),形成关键的8-8键,用于表征所有木脂素天然产物。随后的转化,包括母体支架的环化和氧化,将最初形成的二聚体转化为各种家庭成员,赋予独特的功能。虽然这一蓝图已经成为几十年来木脂素仿生合成方法的关键灵感来源,但氧化偶联中的选择性问题导致研究人员选择了替代的、面向目标的途径,这些途径通常针对单个结构类。在这篇综述中,我们总结了从2009年到2016年的最新研究成果,并概述了当代对木脂素的研究成果。上一页木聚糖
Nature has long served as an important source of therapeutics, and lignans represent a large class of pharmacologically active compounds (Cunha et al. 2012). This family of molecules demonstrates a wide range of biological activities, which plants use as a front‐line chemical defence against pathogens (Figure 1.1). Additionally, the anticancer, antimiotic, antiangiogenesis and antiviral properties possessed by lignans have made them appealing drug candidates, as well as starting points for drug discovery. Lignans currently employed for healthcare include (−)‐podophyllotoxin (1), a treatment for warts, and its derivatives (−)‐etoposide (2) and (−)‐teniposide (3), two potent chemotherapeutic agents (Liu et al. 2007). Other members of this class with promising biological activities include (+)‐gomisin J (4) and (+)‐pinoresinol (5). Due to the established benefits of the lignans, both their biosynthesis and synthetic strategies to access them have been areas of extensive research. In addition to their varied biological activities, lignans comprise a vast array of structurally distinct skeletons (Figure 1.2), including 6‐ and 8‐membered carbocycles (6, 7), linear dibenzylbutanes (8), and diversely oxidized tetrahydrofurans (9–11). Remarkably, their biosynthesis originates from a regio‐ and stereoselective, oxidative coupling of relatively simple monolignols (propenyl phenols) (12), to form the key 8–8 bond that serves to characterize all lignan natural products. Subsequent transformations, including cyclization and oxidation of the parent scaffold, convert the initially formed dimer to various family members, imparting unique functionalities. While this blueprint has served as a key source of inspiration for decades of biomimetic synthetic approaches to the lignans, issues of selectivity in the oxidative coupling have led researchers to alternative, target‐oriented routes, which are often specific for an individual structural class. In this review, we summarize these recent efforts from 2009 to 2016, and provide an overview of contemporary research efforts interrogating the lignans. Previous The Lignans